Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy
Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the clinical safety, tolerability, and efficacy of
clobazam (Onfi) when it replaces the pre-existing clonazepam therapy in patients with
refractory epilepsy.